Template:SUIT-006 O2 ce-pce D029: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) No edit summary ย |
||
(10 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
[[Image:SUIT-MitoFit.png|right|190px|link=http://www.bioblast.at/index.php/MitoPedia:_SUIT |MitoPedia: SUIT]] | [[Image:SUIT-MitoFit.png|right|190px|link=http://www.bioblast.at/index.php/MitoPedia:_SUIT |MitoPedia: SUIT]] | ||
== Steps and respiratory states == | == Steps and respiratory states == | ||
[[File:Ce1;1Dig;1PM;2D;2c; | [[File:Ce1;1Dig;1PM;2D;2c;3Omy;4U;5Ama.png|600px]] | ||
{{Template:SUIT cells}} | {{Template:SUIT cells}} | ||
Line 11: | Line 11: | ||
|- | |- | ||
| 1PM | | 1PM | ||
| [[PM]]<sub>'' | | [[PM]]<sub>[[LEAK respiration|''L''(n)]]</sub> ย | ||
| [[N]] | | [[N]] | ||
| CI | | CI | ||
Line 41: | Line 41: | ||
|- | |- | ||
| | | 3Omy | ||
| [[PM]]<sub>'' | | [[PM]]<sub>[[LEAK respiration|''L''Omy]]</sub> | ||
| [[N]] | | [[N]] | ||
| CI | | CI | ||
| 1PM;2D;2c;3Omy | | 1PM;2D;2c;3Omy | ||
*{{Template:SUIT N}} | |||
*{{Template:SUIT L(Omy)}} ย | *{{Template:SUIT L(Omy)}} ย | ||
*The addition of [[oligomycin]] is optional depending on the experimental question to resolve. If it is known that ''L''<sub>n</sub> has the same values for ''L''<sub>Omy</sub> for a kind of sample and substrates, this step may be skipped. If the carrier of oligomycin (EtOH) is used instead, it is possible to evaluate whether it affects | *The addition of [[oligomycin]] is optional depending on the experimental question to resolve. If it is known that ''L''<sub>n</sub> has the same values for ''L''<sub>Omy</sub> for a kind of sample and substrates, this step may be skipped. If the carrier of oligomycin (EtOH) is used instead, it is possible to evaluate whether it affects respiration. In these cases, LEAK state is not reached again. ย | ||
|- | |- | ||
Line 70: | Line 71: | ||
|} | |} | ||
ย | {{Keywords: SUIT protocols}} | ||
{{ |
Latest revision as of 13:09, 25 November 2020
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
ce1 | ROUTINE | ce1
| ||
1Dig | REN | ce1;1Dig
|
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M)
|
---|---|---|---|---|
1PM | PML(n) | N | CI | 1PM
|
2D | PMP | N | CI | 1PM;2D
|
2c | PMcP | N | CI | 1PM;2D;2c
|
3Omy | PMLOmy | N | CI | 1PM;2D;2c;3Omy
|
4U | PME | N | CI | 1PM;2D;2c;3Omy;4U
|
5Ama | ROX | 1PM;2D;2c;3Omy;4U;5Ama
|
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- ยป Electron transfer pathway
- ยป Fatty acid oxidation pathway control state, F
- ยป NADH electron transfer-pathway state, N
- ยป Succinate pathway control state, S
- ยป NS-pathway control state, NS
- ยป Glycerophosphate pathway control state, Gp
- ยป Complex IV single step, CIV
- ยป Anaplerotic pathway control state
- Pathway control
- Main fuel substrates
- ยป Glutamate, G
- ยป Glycerophosphate, Gp
- ยป Malate, M
- ยป Octanoylcarnitine, Oct
- ยป Pyruvate, P
- ยป Succinate, S
- Main fuel substrates
- Glossary